Marshall Wace, LLP Acrivon Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 181,187 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,187
Previous 450,391
59.77%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACRV
# of Institutions
54Shares Held
18.5MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio